Zurcher Kantonalbank (Zurich Cantonalbank) Revance Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 32,961 shares of RVNC stock, worth $84,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,961

Previous 32,961 -0.0%

Holding current value

$84,709

Previous $84,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$2.34 - $4.73 $24,892 - $50,317	10,638 Added 47.65%	32,961 $84,000
Q1 2024 Apr 25, 2024	BUY	$4.65 - $9.31 $19,716 - $39,474	4,240 Added 23.45%	22,323 $109,000
Q3 2023 Oct 25, 2023	BUY	$11.47 - $25.07 $30,074 - $65,733	2,622 Added 16.96%	18,083 $207,000
Q2 2023 Aug 07, 2023	BUY	$24.7 - $37.61 $28,009 - $42,649	1,134 Added 7.92%	15,461 $391,000
Q1 2023 May 08, 2023	BUY	$18.36 - $35.27 $8,372 - $16,083	456 Added 3.29%	14,327 $461,000
Q4 2022 Feb 01, 2023	BUY	$18.32 - $30.66 $109,718 - $183,622	5,989 Added 75.98%	13,871 $256,000
Q2 2020 Jul 28, 2020	BUY	$12.6 - $26.55 $51,345 - $108,191	4,075 Added 107.04%	7,882 $192,000
Q1 2020 May 06, 2020	BUY	$12.46 - $27.81 $13,456 - $30,034	1,080 Added 39.6%	3,807 $56,000
Q3 2019 Oct 18, 2019	BUY	$10.22 - $14.5 $12,897 - $18,299	1,262 Added 86.14%	2,727 $35,000
Q1 2019 Apr 29, 2019	SELL	$15.4 - $20.39 $13,659 - $18,085	-887 Reduced 37.71%	1,465 $23,000
Q4 2018 Jan 25, 2019	BUY	$18.06 - $24.96 $20,931 - $28,928	1,159 Added 97.15%	2,352 $47,000
Q4 2017 Jan 31, 2018	BUY	$24.55 - $36.3 $19,959 - $29,511	813 Added 213.95%	1,193 $43,000
Q3 2017 Nov 08, 2017	BUY	$22.55 - $28.1 $8,569 - $10,678	380	380 $10,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Revance Therapeutics, Inc. Transaction History